PROLANIS IMPLEMENTATION EFFECTIVE TO CONTROL FASTING BLOOD SUGAR, HBA1C AND TOTAL CHOLESTEROL LEVELS IN PATIENTS WITH TYPE 2 DIABETES
ABSTRACT: Diabetes mellitus
(DM) is a global disease endemic and causing of 4.6 million deaths in the
world. The Indonesian government and health insurance [BPJS Kesehatan]
formulate a Chronic Disease Care Program [Program Pengelolaan Penyakit Kronis
(PROLANIS)] for type 2 diabetes that aimed at controlling the glycemic status
and the risk factors of macro and microvascular complications. The purpose of
this study was to analyze the correlation between the implementation of
PROLANIS and fasting blood sugar, HbA1c, and total cholesterol levels in
patients diagnosed with type 2 diabetes at Antang and Pampang community health
centers, Makassar, Indonesia. Methods: This study used descriptive correlation
design with cross sectional study approach. Subjects were 40 patients diagnosed
with type 2 diabetes who joined PROLANIS at PUSKESMAS Antang and Pampang,
Makassar, with sampling technique used was total sampling. The data were
analyzed using correlation test to assess the significance (p), the direction
(+/-), and the strength of the correlation (r). The implementation of PROLANIS
was measured by using the observation sheets developed based on BPJS Kesehatan
criteria, while the fasting blood sugar, HbA1c, and total cholesterol levels
were checked by laboratory. Results: The mean of the implementation of PROLANIS
was 15.05 (SD ± 5.62), while the mean levels of fasting blood sugar, HbA1c, and
total cholesterolwere as followed: 191.80 mg/dL (SD ± 85.15); 8.4% (SD ± 2.08);
and 192.87 mg/dL (SD ± 45.07). Using the Spearman's rho test, the study result
showed that there was a significant and negative correlation between the
implementation of PROLANIS and the levels of fasting blood sugar (p= 0.001; r=
-0.724), HbA1c (p= 0.001; r= -0.870), and total cholesterol (p= 0.029; r=
-0.35) in patients diagnosed with type 2 diabetes at Puskemas Antang and Pampang,
Makassar. Conclusions: The optimal implementation of the PROLANIS is very
effective to control the levels of fasting blood sugar, HbA1c, and total
cholesterol in patients type 2 diabetes.
KEYWORDS: Fasting Blood Sugar,
HbA1c,PROLANIS, Primary Health Center, Type 2 Diabetes
Author: Musfirah Ahmad, Rini
Rachmawaty, Elly L. Sjattar, Saldy Yusuf
Journal Code: jpkesmasgg170026
